Location History:
- Edison, NJ (US) (1991 - 2006)
- Colonia, NJ (US) (2007 - 2015)
Company Filing History:
Years Active: 1991-2015
Title: **Hyun O Ok: Innovator in Platelet-Activating Factor Antagonists**
Introduction
Hyun O Ok, based in Edison, NJ, is a notable inventor with a remarkable portfolio of 20 patents. His contributions to the field of biochemistry and pharmacology demonstrate a profound commitment to addressing critical health issues through innovative solutions.
Latest Patents
Among his most recent patents, Ok developed compounds that function as platelet-activating factor (PAF) receptor antagonists. The first patent focuses on cyclohexyl sulfonamide compounds, which hold promise for treating atherosclerosis and other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders. These compounds are crucial in advancing therapeutic options for patients suffering from such conditions.
Another significant invention by Ok involves benzimidazole and aza-benzimidazole carboxamides. This patent provides compounds of Formula I, recognized as PAFR antagonists, which can effectively treat PAF-mediated disorders. These compounds are particularly beneficial for treating atherosclerosis and reducing the risk of atherosclerotic disease events. They also play a role in alleviating pain, particularly inflammatory and nociceptive pain, as well as managing autoimmune and inflammatory diseases.
Career Highlights
Hyun O Ok has had a prosperous career, collaborating with major pharmaceutical companies. He has worked for Merck & Company, Inc. and Merck Sharp & Dohme Corporation, where he has contributed significantly to research and development within the pharmaceutical industry. His work highlights the impact of innovative treatment solutions on public health.
Collaborations
Throughout his career, Ok has collaborated with distinguished colleagues, including Michael H. Fisher and Ann E. Weber. These collaborations have facilitated advancements in research, leading to significant contributions in the development of compounds aimed at serious health conditions.
Conclusion
Hyun O Ok's innovative work in the area of platelet-activating factor receptor antagonists underscores his role as a key figure in biomedical research. His patents reflect a commitment to improving therapeutic strategies for various disorders, marking him as a prominent inventor in the pharmaceutical industry. Through his efforts, Ok continues to pave the way for advancements that hold the potential to transform patient care and treatment outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.